πŸ“¦ At-home kits now available.Order your kit β†’
Guide
Review
Beginner
For Patients

Supplements for Microclots: Which Have Any Evidence?

Tim Ottowitz Published 7 min read

Short answer

No supplement has been shown to dissolve microclots in people. Nattokinase, lumbrokinase, serrapeptase and bromelain have only been tested on microclots or spike protein in lab dishes, plus two patients in one unpublished thesis. Each can thin blood or interact with blood thinners. Whether to take one is a decision for your clinician.

Abstract illustration of green enzyme shapes next to a hexagonal lattice breaking into fragments

Key takeaways

  • 1No published human trial has measured microclots before and after any supplement.
  • 2Serrapeptase has one master's thesis on Long COVID plasma and two treated patients; it hasn't been published in a journal.
  • 3The bromelain and acetylcysteine spike work was done on proteins and virus in lab dishes, not on microclots.
  • 4The nattokinase, bromelain and curcumin 'spike detox' regimen was published as a clinical rationale paper, not a trial.
  • 5Supplements aren't approved or tested by the FDA before sale, and several can raise bleeding risk.

No supplement has been shown to dissolve microclots in people. The best-supported claims come from lab dishes, and the human trials that exist measured other things, such as stroke events or fibrinogen. This page ranks what was actually tested, in what model, and what the safety trade-offs are.

Microclots themselves are still a research finding with no validated clinical test and no accepted treatment. If you want the debate first, read are microclots real and what microclots are.

Which supplements for microclots have any evidence?

Four proteolytic enzymes get most of the attention, and none has a published human trial that counted microclots. The table separates what was tested on microclots or spike protein from what was tested in people for any clotting outcome.

SupplementWhat it isEvidence on microclots or spike/fibrinHuman clinical evidence (any clotting outcome)Main safety concernVerdict
NattokinaseEnzyme from fermented soybeans (natto)In vitro: cut lab-made microclot counts (2024 preprint); no significant effect on plasma-derived microclots (2026 study)12 healthy men, one dose: clotting markers changed. No microclot measurementBleeding, especially with blood thinnersMixed lab data
LumbrokinaseGroup of enzymes from earthwormsIn vitro: with 500 kHz ultrasound, reduced clot size and large-clot count in pig-plasma microclots310 stroke patients, 12 months: fibrinogen and vascular events reported. No microclot measurementBleedingLab hints, no microclot trial
Serrapeptase (serratiopeptidase)Enzyme from Serratia bacteriaIn vitro on Long COVID plasma and 2 treated patients, in one unpublished thesisSystematic review: evidence for pain and inflammation use is weak; nothing on clotting outcomesLong-term safety data lackingThesis-level data only
BromelainEnzyme mix from pineapple stemsIn vitro: with acetylcysteine, disrupted spike protein and inactivated virus. Not tested on microclotsNone for microclots; MSK says no clinical proof for circulationBruising and bleeding; allergyTest tube only

Curcumin and omega-3 aren't in the table because we found no microclot- or fibrin-amyloid-specific study on either.

What does the nattokinase evidence show?

Nattokinase has the most microclot data and the data disagree. A 2024 preprint found it reduced the number of lab-made microclots, built from purified fibrinogen, thrombin and bacterial toxin (Grixti et al.). A 2026 study using amyloid microclots made from pig plasma found nattokinase alone didn't shrink them, and with 500 kHz ultrasound it cut the number of large clots but not average clot size (Rasouli et al.).

Swallowed nattokinase does change blood markers: a placebo-controlled crossover in 12 healthy young men found higher D-dimer and longer clotting time after one dose (Kurosawa et al., 2015). It didn't look at microclots. Our nattokinase deep dive compares all eight studies.

Does lumbrokinase work better than nattokinase?

There's no human comparison, so nobody can say. In the 2026 plasma study, enzymes added nothing significant at 150 or 300 kHz; at 500 kHz lumbrokinase reduced clot size, and both enzymes reduced the number of large clots (Rasouli et al.).

Lumbrokinase does have a larger human trial than most supplements: 310 stroke patients randomized to standard care with or without lumbrokinase for a year. The authors reported lower fibrinogen and fewer vascular events in the lumbrokinase group (Cao et al., 2013). The control group got no placebo and the trial measured no microclots, so it speaks to stroke prevention, not microclots.

Does serrapeptase dissolve microclots?

Only one source has tested it, and it's a thesis, not a journal paper. A 2024 master's thesis from Stellenbosch, supervised by Resia Pretorius, treated platelet-poor plasma from 50 Long COVID patients and 45 controls with serrapeptase or nattokinase in vitro (Usher, 2024).

Microscopy showed a sevenfold drop in amyloid area with serrapeptase and sixfold with nattokinase. Flow cytometry disagreed: serrapeptase cut microclot counts threefold while nattokinase showed no significant change. Two patients then took the enzymes for three weeks, one on nattokinase and one on both, and their amyloid area fell tenfold and 28-fold. Two patients with no control group can't show cause.

For broader use, the 2013 systematic review of serratiopeptidase found the evidence for pain and inflammation was "insufficient" and that safety data were lacking (Bhagat et al.). We found no peer-reviewed serrapeptase microclot paper in Europe PMC (searched 18 November 2026).

Does bromelain break down microclots?

Not as far as anyone has shown. The study people cite combined bromelain with acetylcysteine (BromAc) and found it disrupted recombinant spike and envelope proteins and inactivated SARS-CoV-2 in cell culture, while the single agents didn't inactivate the virus (Akhter et al., 2021). That's an in vitro study on spike protein and virus. It didn't test fibrin amyloid microclots, and the authors described nasal use as the next clinical step.

Memorial Sloan Kettering says bromelain prevented clotting in lab experiments but there's no clinical trial proof for circulatory disorders (MSK).

Next step

See whether fibrin amyloid is present in your blood

Our at-home test gives laboratory observational data you can share with your clinician. It isn't a diagnosis.

What is the "spike detox" protocol, and is it proven?

It's a regimen of nattokinase, bromelain and curcumin proposed in a 2023 clinical rationale paper by McCullough and colleagues in the Journal of American Physicians and Surgeons. It's a hypothesis and review article, not a trial. The authors wrote that no therapeutic claims can be made until large randomized placebo-controlled trials are completed (McCullough et al., 2023).

FactCheck.org reported that the journal isn't indexed by Medline and that the spike-degradation studies the paper cites were done in vitro (FactCheck.org, 2023). Our spike protein testing guide covers what spike assays can and can't measure.

Are these supplements safe with blood thinners?

They can add to bleeding risk, and the interactions haven't been well studied. MSK lists warfarin and other blood thinners as a "do not take" for bromelain because preclinical studies suggest more bruising and bleeding, and notes it can raise tetracycline levels (MSK). Nattokinase lengthened clotting time in the 2015 trial. The NIH's NCCIH says some supplements may increase bleeding risk or affect your response to anesthesia, so tell your care team well before surgery (NCCIH).

Quality is a separate problem. The FDA doesn't approve dietary supplements before they're sold, doesn't routinely test them, and sets no limit on the amount of an ingredient per serving (FDA). NCCIH adds that what's on the label may not be what's in the product. Enzyme potency isn't comparable across products, which is another reason this page gives no doses.

Our pages on clot-busting flares versus bleeding and triple anticoagulant therapy cover the bleeding side in more detail. Aspirin for microclots covers the antiplatelet question.

Call emergency services at once for sudden chest pain, shortness of breath, a swollen painful leg, face drooping, weakness on one side, or speech trouble. Those can be a large clot, not a microclot, and no supplement is a substitute for urgent care. Black stools, vomiting blood or a severe headache while on any of these also need urgent attention.

How do I know if a supplement is working on microclots?

You can't tell from how you feel, and no test is validated for it. There's no accepted microclot reference range or treatment target, and results depend on how blood is collected and processed. See how to test for microclots for the methods. Symptoms in Long COVID also fluctuate on their own, so improvement after a supplement doesn't show the supplement did it.

Where does our test fit?

Our amyloid test is an at-home Thioflavin T fluorescence microscopy test on a finger-prick dried blood sample, analysed at a partner laboratory in Mexico City. It reports counts and sizes of glowing amyloid shapes. It isn't a diagnosis, and it isn't validated against the venous platelet-poor-plasma method used in published research. It can't show whether a supplement caused any change, and it won't tell you whether to take one. Share any report with the clinician who manages your medicines.

What to do next

Treat every supplement here as unproven for microclots, and bring the list of what you take to your prescriber or pharmacist, especially before surgery. For the wider treatment picture, read microclots treatment, and see microclots versus ordinary blood clots for which symptoms need emergency care.

Frequently asked questions

What supplements dissolve microclots?

None has been proven to. Nattokinase degraded lab-made microclots in one preprint but not plasma-derived ones in a 2026 study. Serrapeptase reduced amyloid area in Long COVID plasma in a thesis, and bromelain has only spike-protein dish data. No trial in people has measured microclots before and after any supplement.

Is serrapeptase or nattokinase better for microclots?

Nobody knows. One master's thesis from the Pretorius lab tested both on Long COVID plasma and reported a larger drop in amyloid area with serrapeptase, but the flow cytometry results differed and only two patients were treated. No head-to-head trial in people exists, and nattokinase alone failed on plasma-derived clots in a separate study.

Does bromelain break down microclots?

Not shown. Bromelain with acetylcysteine disrupted recombinant spike protein and inactivated virus in cell culture in a 2021 study, but that was not microclots and not people. Memorial Sloan Kettering notes bromelain prevented clotting in lab experiments, with no clinical trial proof for circulation problems, and it may raise bruising and bleeding risk.

Is lumbrokinase stronger than nattokinase?

There's no human comparison. In one dish study of pig-plasma microclots, neither enzyme worked alone; with 500 kHz ultrasound both reduced the number of large clots, and only lumbrokinase reduced clot size. Lumbrokinase has a 310-patient stroke-prevention trial, but it measured fibrinogen and vascular events, not microclots, so it can't tell you which enzyme is stronger against them.

Are microclot supplements safe with blood thinners?

Not without your prescriber knowing. Bromelain may raise bruising and bleeding risk with warfarin and other blood thinners, and nattokinase lengthened clotting time in a small trial. Interactions with anticoagulants and antiplatelets are poorly studied. Don't add or stop anything yourself; stop and seek care for unusual bleeding.

How do I know if a supplement is working on microclots?

You can't tell from symptoms alone. There's no validated microclot test, reference range or target level, and microscopy results vary with how blood is collected and processed. A before-and-after result is observational and can't show a supplement caused a change. Your clinician can help you track symptoms and safety markers.

Sources

  1. Serratiopeptidase: a systematic review of the existing evidence. International Journal of Surgery, 2013
  2. The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2. Viruses, 2021
  3. The fibrinolytic potential of proteolytic enzymes on plasma microclots: a comparative analysis of long COVID patients using fluorescence microscopy and imaging flow cytometry (MSc thesis, Stellenbosch University). Stellenbosch University, 2024
  4. Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial. Chinese Medical Journal, 2013
  5. Investigation of the synergistic effect of enzymatic and ultrasound-induced amyloid microclot degradation. Journal of Thrombosis and Thrombolysis, 2026
  6. Automated microscopic measurement of fibrinaloid microclots and their degradation by nattokinase, the main natto protease. bioRxiv (preprint), 2024
  7. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Scientific Reports, 2015
  8. Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes. Journal of American Physicians and Surgeons, 2023
  9. Posts Push Unproven 'Spike Protein Detoxification' Regimen. FactCheck.org, 2023
  10. Bromelain: purported benefits, side effects, and more. Memorial Sloan Kettering Cancer Center, 2025
  11. Using Dietary Supplements Wisely. National Center for Complementary and Integrative Health (NIH), 2019
  12. Questions and Answers on Dietary Supplements. U.S. Food and Drug Administration, 2026

At-Home Amyloid Test

See whether fibrin amyloid is present in your blood

Our at-home test gives laboratory observational data you can share with your clinician. It isn't a diagnosis.

    Next steps

    Tim Ottowitz

    Tim Ottowitz

    Founder & Research Lead

    Tim Ottowitz founded Amyloid Test and writes its Science Hub, turning fibrin amyloid and spike protein research into plain-language guides that stay close to the published evidence.

    Keep reading

    Illustration of fibrin strands forming a clot, the mesh that anticoagulant and antiplatelet drugs act on in different ways
    Guide
    Review

    Aspirin for Microclots: What the Evidence Shows and Doesn't

    Does aspirin help microclots? An antiplatelet that doesn't break down fibrin, with no trial in Long COVID. What studies found and the bleeding risks.

    Tim OttowitzNov 18, 2026
    6m
    AT
    Guide
    Review

    Nattokinase Flare vs Bleeding: Microclot Symptoms and Risks

    Is your nattokinase flare a healing crisis or dangerous bleeding? Learn how to distinguish reperfusion symptoms from anticoagulant risks and microclots.

    Tim OttowitzOct 19, 2026
    7m
    Illustration of fibrin strands forming a clot, the target of anticoagulant and antiplatelet drugs
    Guide
    Observational

    Triple Therapy for Long COVID: 2026 Evidence and Bleeding Risks

    What triple anticoagulant therapy for long COVID involves, what the only published cohort found, why haematologists object, and the bleeding risks.

    Tim OttowitzOct 16, 2026
    6m